KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Long-Term Investments (2016 - 2025)

Biogen has reported Long-Term Investments over the past 16 years, most recently at $431.9 million for Q4 2025.

  • Quarterly results put Long-Term Investments at $431.9 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $431.9 million (changed N/A YoY), and the annual figure for FY2025 was $431.9 million, changed.
  • Long-Term Investments for Q4 2025 was $431.9 million at Biogen, up from $100000.0 in the prior quarter.
  • Over the last five years, Long-Term Investments for BIIB hit a ceiling of $1.2 billion in Q2 2023 and a floor of $100000.0 in Q3 2023.
  • Median Long-Term Investments over the past 4 years was $903.6 million (2021), compared with a mean of $823.8 million.
  • Biggest five-year swings in Long-Term Investments: rose 21.86% in 2022 and later plummeted 99.99% in 2023.
  • Biogen's Long-Term Investments stood at $892.0 million in 2021, then fell by 20.89% to $705.7 million in 2022, then crashed by 99.99% to $100000.0 in 2023, then surged by 431800.0% to $431.9 million in 2025.
  • The last three reported values for Long-Term Investments were $431.9 million (Q4 2025), $100000.0 (Q3 2023), and $1.2 billion (Q2 2023) per Business Quant data.